RxDoctor Payments DataLook up a doctor →

Peter Mattar, MD

Family Medicine · Fontana, CANPI 1417005422

Payments from drug & device makers

$2,266,329in general payments, 2019–2025

Across 184 payments — averaging $12,317 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$1.3M
  • Pacira Therapeutics, Inc.$562K
  • Organogenesis Inc.$157K
  • Welch Allyn$102K
  • Anika Therapeutics, Inc.$58K
  • Sun Pharmaceutical Industries Inc.$51K
  • plus $74K from 27 others
$1,403in research payments, 2019–2025

Across 3 payments — averaging $467.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,266,329 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$19,856
Medicare patients
96
Services billed
207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Fontana

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →